• Recherche translationnelle en santé,


    technologie pour la santé et recherche clinique

    https://tonic.inserm.fr/wp-content/uploads/2019/09/OlivierRascol.jpe
     

    Olivier RASCOL

    PU-PH

      Publications rédigées ou co-rédigées

    • > 2- Personality dimensions of patients can change during the course of parkinson’s disease.

      Boussac M, Arbus C, Dupouy J, Harroch E, Rousseau V, Croiset A, Ory-Magne F, Rascol O, Moreau C, Rolland AS, Maltête D, Rouaud T, Meyer M, Drapier S, Giordana B, Anheim M, Hainque E, Jarraya B, Benatru I, Auzou N, Belamri L, Tir M, Marques AR, Thobois S, Eusebio A, Corvol JC, Devos D, Brefel-Courbon C; PREDI-STIM study group.
      See the publication

      PLoS One. 2021 Jan 7;16(1):e0245142. doi: 10.1371/journal.pone.0245142.
    • > 7- Parkinson’s Disease Drug Development Since 1999: A Story of Repurposing and Relative Success.

      Boucherie DM, Duarte GS, Machado T, Faustino PR, Sampaio C, Rascol O, Ferreira JJ.
      <a
      <a
      <a
      See the publication

      J Parkinsons Dis. 2021 Jan 11. doi: 10.3233/JPD-202184.